Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
EFFECT
Notice of effectiveness
4 Apr 24
424B2
Prospectus for primary offering
3 Apr 24
S-3
Shelf registration
27 Mar 24
8-K
Other Events
27 Mar 24
8-K
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
27 Mar 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
21 Mar 24
8-K
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
13 Mar 24
8-K
Pyxis Oncology Announces $50 Million Private Placement
28 Feb 24
8-K
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
28 Nov 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
7 Nov 23
8-K/A
Index to Consolidated Financial Statements
27 Oct 23
UPLOAD
Letter from SEC
6 Sep 23
CORRESP
Correspondence with SEC
28 Aug 23
EFFECT
Notice of effectiveness
25 Aug 23
S-8 POS
Registration of securities for employees (post-effective amendment)
23 Aug 23
POS AM
Prospectus update (post-effective amendment)
23 Aug 23
S-8
Registration of securities for employees
23 Aug 23
8-K
Pyxis Oncology Successfully Completes Acquisition of Apexigen
23 Aug 23
UPLOAD
Letter from SEC
16 Aug 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
425
Business combination disclosure
11 Aug 23
8-K
Pyxis Oncology Reports Financial Results for Second-Quarter 2023
11 Aug 23
425
Business combination disclosure
11 Aug 23
8-K
Other Events
11 Aug 23
EFFECT
Notice of effectiveness
3 Jul 23
425
Business combination disclosure
30 Jun 23
8-K
Departure of Directors or Certain Officers
30 Jun 23
424B3
Prospectus supplement
30 Jun 23
CORRESP
Correspondence with SEC
29 Jun 23
UPLOAD
Letter from SEC
15 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
13 Jun 23
S-4
Registration of securities issued in business combination transactions
8 Jun 23
425
Business combination disclosure
30 May 23
425
Business combination disclosure
25 May 23
Latest ownership filings
SC 13D/A
Sullivan Lara
3 Apr 24
4
Pamela Ann Connealy
28 Mar 24
4
Lara Sullivan
28 Mar 24
4
JOHN L FLAVIN
28 Mar 24
4
Darren S Cline
28 Mar 24
4
Freda C Lewis-Hall
28 Mar 24
4
Jakob Dupont
28 Mar 24
4
RACHEL HUMPHREY
28 Mar 24
4
Thomas Civik
28 Mar 24
4
Jitendra Wadhane
28 Mar 24
4
Santhosh Palani
13 Mar 24
3
Santhosh Palani
13 Mar 24
SC 13G
Deep Track Capital, LP
8 Mar 24
SC 13G/A
TANG CAPITAL PARTNERS LP
14 Feb 24
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
14 Feb 24
4
Ken Kobayashi
29 Dec 23
3
Ken Kobayashi
6 Dec 23
4
Pamela Ann Connealy
30 Nov 23
4
Jitendra Wadhane
17 Nov 23
4
Pamela Ann Connealy
28 Sep 23
4
Jitendra Wadhane
27 Sep 23
4
Pamela Ann Connealy
27 Sep 23
4
Jakob Dupont
26 Sep 23
4
Jitendra Wadhane
25 Sep 23
4
Pamela Ann Connealy
25 Sep 23
4
Jitendra Wadhane
22 Sep 23
4
Pamela Ann Connealy
22 Sep 23
4
Lara Sullivan
18 Sep 23
144
Notice of proposed sale of securities
18 Sep 23
144
Notice of proposed sale of securities
14 Sep 23
4
Lara Sullivan
13 Sep 23
144
Notice of proposed sale of securities
13 Sep 23
144
Notice of proposed sale of securities
12 Sep 23
144
Notice of proposed sale of securities
11 Sep 23
4
Pamela Ann Connealy
8 Sep 23
4
Jitendra Wadhane
8 Sep 23
4
Lara Sullivan
8 Sep 23
144
Notice of proposed sale of securities
5 Sep 23
4
Jakob Dupont
25 Aug 23
3
Jakob Dupont
25 Aug 23